Vivos (RDGL) Common Equity (2010 - 2025)
Vivos (RDGL) reported Common Equity of $1.7 million for Q4 2025, down 22.65% on a YoY basis from $2.1 million in Q4 2024, and down 23.9% sequentially from $2.2 million in Q3 2025.
Vivos (RDGL) Common Equity (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Common Equity data on file, last reported at $1.7 million in Q4 2025.
- For the quarter ending Q4 2025, Common Equity fell 22.65% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 22.65% YoY), and the FY2025 full-year result was $1.7 million, down 22.65% from the prior year.
- Common Equity declined to $1.7 million in Q4 2025, from $2.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $3.2 million in Q1 2025 to a low of $893020.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2021 frame the typical range for Common Equity.
- Across the five-year window, Common Equity surged 4480.7% in 2021 and sank 45.06% in 2022, its largest moves.
- Tracing RDGL's Common Equity over 5 years: stood at $1.5 million in 2021, then rose by 13.2% to $1.7 million in 2022, then fell by 17.82% to $1.4 million in 2023, then surged by 57.29% to $2.1 million in 2024, then declined by 22.65% to $1.7 million in 2025.
- Business Quant data shows RDGL's Common Equity at $1.7 million in Q4 2025, $2.2 million in Q3 2025, and $2.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.96 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.67 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 5.29 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 13.34 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 893,020.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.63 Mn |
| Mar 31, 2021 | 1.83 Mn |